Our Halo-Lido trial willhave finalpatient byend of 2022There are noFDAapproveddrugs to treathemorrhoidsMyron Holubiakand I founded aprivatecompany in2013Mino-Lokis our leadassetI'm ashareholdermyselfWe intendto submita BLA in2H 2022I/Ontak isour leadassetI won't diluteshareholdersMino-WrapWe expect tofinish theMino-Loktrial this yearWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mNot manycompaniesthis size with2 late stageassetsMino-Lokpotentialmarket>$1BHemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.An actualiMSCupdateI/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022There are noFDAapproveddrugs to treathemorrhoidsMyron Holubiakand I founded aprivatecompany in2013Mino-Lokis our leadassetI'm ashareholdermyselfWe intendto submita BLA in2H 2022I/Ontak isour leadassetI won't diluteshareholdersMino-WrapWe expect tofinish theMino-Loktrial this yearWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mNot manycompaniesthis size with2 late stageassetsMino-Lokpotentialmarket>$1BHemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.An actualiMSCupdateI/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacy

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
B
2
I
3
O
4
I
5
G
6
O
7
G
8
G
9
N
10
B
11
O
12
B
13
O
14
I
15
G
16
B
17
I
18
G
19
O
20
I
21
N
22
B
23
N
24
N
  1. B-Our Halo-Lido trial will have final patient by end of 2022
  2. I-There are no FDA approved drugs to treat hemorrhoids
  3. O-Myron Holubiak and I founded a private company in 2013
  4. I-Mino-Lok is our lead asset
  5. G-I'm a shareholder myself
  6. O-We intend to submit a BLA in 2H 2022
  7. G-I/Ontak is our lead asset
  8. G-I won't dilute shareholders
  9. N-Mino-Wrap
  10. B-We expect to finish the Mino-Lok trial this year
  11. O-We have enough cash to go well into 2023
  12. B-We will open up international sites for Mino-Lok trial
  13. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  14. I-We will have exclusivity
  15. G-Only biotech with 2 Myron's on the leadership team
  16. B-Insiders invested $26.5m
  17. I-Not many companies this size with 2 late stage assets
  18. G-Mino-Lok potential market >$1B
  19. O-Hemorrhoids is a $2B market
  20. I-I/ONTAK was the best deal I ever made
  21. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  22. B-An actual iMSC update
  23. N-I/ONTAK's potential market is >$300m
  24. N-We had a phase 2b trial with 100% efficacy